566 related articles for article (PubMed ID: 19932777)
1. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
Hallén J; Buser P; Schwitter J; Petzelbauer P; Geudelin B; Fagerland MW; Jaffe AS; Atar D
Am J Cardiol; 2009 Dec; 104(11):1472-7. PubMed ID: 19932777
[TBL] [Abstract][Full Text] [Related]
2. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
5. Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial.
Hallén J; Petzelbauer P; Schwitter J; Geudelin B; Buser P; Atar D
EuroIntervention; 2010 Apr; 5(8):946-52. PubMed ID: 20542780
[TBL] [Abstract][Full Text] [Related]
6. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T.
Giannitsis E; Steen H; Kurz K; Ivandic B; Simon AC; Futterer S; Schild C; Isfort P; Jaffe AS; Katus HA
J Am Coll Cardiol; 2008 Jan; 51(3):307-14. PubMed ID: 18206741
[TBL] [Abstract][Full Text] [Related]
7. Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months.
Bøhmer E; Hoffmann P; Abdelnoor M; Seljeflot I; Halvorsen S
Cardiology; 2009; 113(3):207-12. PubMed ID: 19218804
[TBL] [Abstract][Full Text] [Related]
8. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function.
Steen H; Giannitsis E; Futterer S; Merten C; Juenger C; Katus HA
J Am Coll Cardiol; 2006 Dec; 48(11):2192-4. PubMed ID: 17161244
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
[TBL] [Abstract][Full Text] [Related]
12. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.
Ohlmann P; Jaquemin L; Morel O; El Behlgiti R; Faure A; Michotey MO; Beranger N; Roul G; Schneider F; Bareiss P; Monassier JP
Am Heart J; 2006 Dec; 152(6):1161-7. PubMed ID: 17161070
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Atar D; Huber K; Rupprecht HJ; Kopecky SL; Schwitter J; Theek C; Brandl K; Henning R; Geudelin B
Cardiology; 2007; 108(2):117-23. PubMed ID: 17019083
[TBL] [Abstract][Full Text] [Related]
15. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.
Sörensson P; Saleh N; Bouvier F; Böhm F; Settergren M; Caidahl K; Tornvall P; Arheden H; Rydén L; Pernow J
Heart; 2010 Nov; 96(21):1710-5. PubMed ID: 20956486
[TBL] [Abstract][Full Text] [Related]
16. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction.
Andrassy M; Volz HC; Riedle N; Gitsioudis G; Seidel C; Laohachewin D; Zankl AR; Kaya Z; Bierhaus A; Giannitsis E; Katus HA; Korosoglou G
J Intern Med; 2011 Sep; 270(3):245-53. PubMed ID: 21362071
[TBL] [Abstract][Full Text] [Related]
18. Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction.
Husser O; Bodi V; Sanchis J; Nunez J; Mainar L; Rumiz E; Lopez-Lereu MP; Monmeneu JV; Forteza MJ; Oltra R; Riegger GA; Chorro FJ; Llacer A
Thromb Res; 2009 Nov; 124(5):592-600. PubMed ID: 19540571
[TBL] [Abstract][Full Text] [Related]
19. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
[TBL] [Abstract][Full Text] [Related]
20. The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction.
Orn S; Breland UM; Mollnes TE; Manhenke C; Dickstein K; Aukrust P; Ueland T
Am J Cardiol; 2009 Nov; 104(9):1179-83. PubMed ID: 19840558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
